76 related articles for article (PubMed ID: 29843720)
1. Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models.
Liu JY; Lin YP; Qiu H; Morisseau C; Rose TE; Hwang SH; Chiamvimonvat N; Hammock BD
Eur J Pharm Sci; 2013 Mar; 48(4-5):619-27. PubMed ID: 23291046
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
[TBL] [Abstract][Full Text] [Related]
3. miR-448 regulates potassium voltage-gated channel subfamily A member 4 (KCNA4) in ischemia and heart failure.
Kang GJ; Xie A; Kim E; Dudley SC
Heart Rhythm; 2023 May; 20(5):730-736. PubMed ID: 36693615
[TBL] [Abstract][Full Text] [Related]
4. Pairwise biosynthesis of ion channels stabilizes excitability and mitigates arrhythmias.
Jameson MB; Ríos-Pérez EB; Liu F; Eichel CA; Robertson GA
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2305295120. PubMed ID: 37816059
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-mediated control of myocardial infarction in diabetes.
Pérez-Cremades D; Chen J; Assa C; Feinberg MW
Trends Cardiovasc Med; 2023 May; 33(4):195-201. PubMed ID: 35051592
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as biomarkers for myocardial infarction.
Salic K; De Windt LJ
Curr Atheroscler Rep; 2012 Jun; 14(3):193-200. PubMed ID: 22392328
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase inhibition reverses cognitive dysfunction in a mouse model of metabolic syndrome by modulating inflammation.
Bah TM; Davis CM; Allen EM; Borkar RN; Perez R; Grafe MR; Raber J; Pike MM; Alkayed NJ
Prostaglandins Other Lipid Mediat; 2024 May; 173():106850. PubMed ID: 38735559
[TBL] [Abstract][Full Text] [Related]
8. Soluble Epoxide Hydrolase Inhibitors Regulate Ischemic Arrhythmia by Targeting MicroRNA-1.
Chen Y; Liu Q; Yang T; Shen L; Xu D
Front Physiol; 2021; 12():717119. PubMed ID: 34646152
[No Abstract] [Full Text] [Related]
9. Therapeutic Value of miRNAs in Coronary Artery Disease.
Ali Sheikh MS; Alduraywish A; Almaeen A; Alruwali M; Alruwaili R; Alomair BM; Salma U; Hedeab GM; Bugti N; A M Abdulhabeeb I
Oxid Med Cell Longev; 2021; 2021():8853748. PubMed ID: 33953838
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.
Sun CP; Zhang XY; Morisseau C; Hwang SH; Zhang ZJ; Hammock BD; Ma XC
J Med Chem; 2021 Jan; 64(1):184-215. PubMed ID: 33369424
[TBL] [Abstract][Full Text] [Related]
11. Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.
Imig JD; Jankiewicz WK; Khan AH
Hypertension; 2020 Jul; 76(1):3-15. PubMed ID: 32475311
[TBL] [Abstract][Full Text] [Related]
12. Soluble epoxide hydrolase inhibitors, t-AUCB, regulated microRNA-1 and its target genes in myocardial infarction mice.
Gui YJ; Yang T; Liu Q; Liao CX; Chen JY; Wang YT; Hu JH; Xu DY
Oncotarget; 2017 Nov; 8(55):94635-94649. PubMed ID: 29212255
[TBL] [Abstract][Full Text] [Related]
13. A Soluble Epoxide Hydrolase Inhibitor Upregulated KCNJ12 and KCNIP2 by Downregulating MicroRNA-29 in a Mouse Model of Myocardial Infarction.
Zhang X; Liao C; Sun K; Liu L; Xu D
Heart Surg Forum; 2020 Aug; 23(5):E579-E585. PubMed ID: 32990585
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets.
Silvestri P; Di Russo C; Rigattieri S; Fedele S; Todaro D; Ferraiuolo G; Altamura G; Loschiavo P
Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):109-18. PubMed ID: 19519553
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in myocardial infarction.
Fiedler J; Thum T
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):201-5. PubMed ID: 23325477
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.
Gui Y; Li D; Chen J; Wang Y; Hu J; Liao C; Deng L; Xiang Q; Yang T; Du X; Zhang S; Xu D
Lipids Health Dis; 2018 May; 17(1):129. PubMed ID: 29843720
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes.
Liu Q; Zhao X; Peng R; Wang M; Zhao W; Gui YJ; Liao CX; Xu DY
Mol Biosyst; 2017 Feb; 13(3):556-564. PubMed ID: 28112313
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
